Healthpeak Properties

DOC Q4 2025 Earnings

Reported Feb 2, 2026 at 4:18 PM ET · SEC Source

Q4 25 EPS

$0.16

BEAT +132.90%

Est. $0.07

Q4 25 Revenue

$719.4M

BEAT +12.10%

Est. $641.7M

vs S&P Since Q4 25

-5.3%

TRAILING MARKET

DOC -0.8% vs S&P +4.5%

Full Year 2025 Results

FY 25 EPS

$0.10

BEAT +1,100.00%

Est. $-0.01

FY 25 Revenue

$2.82B

BEAT +2.83%

Est. $2.74B

Market Reaction

Did DOC Beat Earnings? Q4 2025 Results

Healthpeak Properties delivered a standout fourth quarter, posting earnings per share of $0.16 against a consensus estimate of $0.07, a beat of 132.90%, while revenue of $719.40 million cleared expectations of $641.73 million by 12.10% and rose 3.1% … Read more Healthpeak Properties delivered a standout fourth quarter, posting earnings per share of $0.16 against a consensus estimate of $0.07, a beat of 132.90%, while revenue of $719.40 million cleared expectations of $641.73 million by 12.10% and rose 3.1% year-over-year. The primary engine behind the outperformance was aggressive capital deployment, headlined by the $600.00 million acquisition of the Gateway Crossing life science campus in South San Francisco and roughly $675.00 million in senior housing investments assembled during the quarter. Perhaps the boldest strategic move was the announced formation of Janus Living, Inc., a dedicated senior housing REIT that Healthpeak plans to take public in the first half of 2026, a structure management believes will unlock value that diversified REITs have historically struggled to capture in public markets, a theme resonating broadly across the healthcare real estate sector. Looking ahead, Healthpeak guided 2026 Nareit FFO per share to $1.70 to $1.74, with same-store NOI growth of negative 1% to positive 1%, as life science fundamentals show early signs of stabilization after a prolonged downturn.

Key Takeaways

  • Total Merger-Combined Same-Store Cash (Adjusted) NOI growth of +3.9% year-over-year in Q4
  • Life Plan same-store NOI growth of +16.7% year-over-year in Q4
  • Outpatient Medical same-store NOI growth of +4.1% year-over-year in Q4
  • Record non-refundable entry fee cash collections of $153 million in 2025
  • Outpatient Medical renewal cash releasing spreads of +4.4% in Q4
  • Lab renewal lease executions averaged 84-month term
  • Q4 new and renewal lease executions totaled 2.1 million square feet
24/7 Wall St

DOC YoY Financials

Q4 2025 vs Q4 2024, source: SEC Filings

24/7 Wall St

DOC Revenue by Segment

With YoY comparisons, source: SEC Filings

Q1 25 Q4 25